A detailed history of Alkeon Capital Management LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Alkeon Capital Management LLC holds 1,167,700 shares of RYTM stock, worth $65.2 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,167,700
Previous 1,000,000 16.77%
Holding current value
$65.2 Million
Previous $41.1 Million 48.99%
% of portfolio
0.11%
Previous 0.07%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.81 - $55.0 $6.84 Million - $9.22 Million
167,700 Added 16.77%
1,167,700 $61.2 Million
Q2 2024

Aug 13, 2024

BUY
$35.41 - $44.37 $35.4 Million - $44.4 Million
1,000,000 New
1,000,000 $41.1 Million
Q2 2023

Aug 11, 2023

SELL
$16.32 - $21.15 $4.75 Million - $6.15 Million
-290,799 Reduced 14.42%
1,725,167 $28.4 Million
Q1 2023

May 12, 2023

SELL
$16.88 - $34.24 $3.75 Million - $7.61 Million
-222,296 Reduced 9.93%
2,015,966 $36 Million
Q4 2022

Feb 13, 2023

BUY
$22.21 - $30.25 $11.8 Million - $16.1 Million
533,262 Added 31.28%
2,238,262 $65.2 Million
Q3 2022

Nov 10, 2022

BUY
$4.3 - $30.85 $881,500 - $6.32 Million
205,000 Added 13.67%
1,705,000 $41.8 Million
Q2 2022

Aug 15, 2022

BUY
$3.12 - $12.25 $4.68 Million - $18.4 Million
1,500,000 New
1,500,000 $6.23 Million
Q1 2018

May 15, 2018

SELL
$19.9 - $32.25 $497,499 - $806,250
-25,000 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$22.0 - $30.51 $550,000 - $762,750
25,000
25,000 $727,000

Others Institutions Holding RYTM

About RHYTHM PHARMACEUTICALS, INC.


  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $3.11B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Alkeon Capital Management LLC Portfolio

Follow Alkeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alkeon Capital Management LLC with notifications on news.